Jang H. Hong

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Circulating Thioredoxin 1 as an Adjunct to Mammography for Breast Cancer Detection: A Multicenter Clinical Validation Study.

Circulating Thioredoxin 1 as an Adjunct to Mammography for Breast Cancer Detection: A Multicenter Clinical Validation Study.

Journal: Cancers

Published: June 25, 2026

A Randomized Double-Blind Placebo-Controlled Trial of a Botanical Formulation for Symptom Management in Male Climacteric Syndrome.

A Randomized Double-Blind Placebo-Controlled Trial of a Botanical Formulation for Symptom Management in Male Climacteric Syndrome.

Journal: Medicina (Kaunas, Lithuania)

Published: May 18, 2026

Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study.

Pharmacokinetic Evaluation of GB-5001, a Long-Acting Injectable Formulation of Donepezil, in Healthy Korean Participants: Population Pharmacokinetics with Phase 1 Study.

Journal: Pharmaceutics

Published: November 03, 2025

CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations.

CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations.

Journal: Pharmacogenomics

Published: September 26, 2025

Genetic Association Between Polymorphisms in lncRNA ANRIL and Gastric Cancer Susceptibility.

Genetic Association Between Polymorphisms in lncRNA ANRIL and Gastric Cancer Susceptibility.

Journal: Genetic testing and molecular biomarkers

Published: September 03, 2025

Exploring LEPR-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese Adults.

Exploring LEPR-Linked Metabolic Diversity through Gut Microbiome-Metabolome Network Analysis in Non-Obese Adults.

Journal: Biomolecules & therapeutics

Published: August 22, 2025

Pharmacokinetics and Safety of a Fixed-Dose Combination of Alogliptin and Extended-Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults.

Pharmacokinetics and Safety of a Fixed-Dose Combination of Alogliptin and Extended-Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults.

Journal: Clinical pharmacology in drug development

Published: January 02, 2025

Comparison of a fixed-dose combination of Celecoxib/PG201 [Layla®] versus co-administration of individual formulations in healthy participants: A randomized trial.

Comparison of a fixed-dose combination of Celecoxib/PG201 [Layla®] versus co-administration of individual formulations in healthy participants: A randomized trial.

Journal: Medicine

Published: November 19, 2024

Pharmacokinetic Drug-Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants.

Pharmacokinetic Drug-Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants.

Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions

Published: September 24, 2024

Clinical data warehouse analysis of clinical laboratory test results of Korean healthy volunteers: does "not clinically significant" range of healthy volunteers need modification?

Clinical data warehouse analysis of clinical laboratory test results of Korean healthy volunteers: does "not clinically significant" range of healthy volunteers need modification?

Journal: Translational and clinical pharmacology

Published: September 12, 2024

Pharmacokinetic comparison of subcutaneously administered CT-P13 (biosimilar of infliximab) via autoinjector and pre-filled syringe in healthy participants.

Pharmacokinetic comparison of subcutaneously administered CT-P13 (biosimilar of infliximab) via autoinjector and pre-filled syringe in healthy participants.

Journal: Clinical and translational science

Published: August 20, 2024

Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.

Phase 1 Evaluation of the Bioequivalence and Drug-Drug Interaction Potential of a Novel Fixed-Dose Combination of Ezetimibe, Atorvastatin, and Amlodipine.

Journal: Clinical pharmacology in drug development

Published: July 09, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026